Muhammad Wasif Saif. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adenocarcinoma/complicationsAdenocarcinoma/drug therapyAdenocarcinoma/metabolismAntineoplastic Agents/administration & dosageCarcinoma, Pancreatic Ductal/complicationsCarcinoma, Pancreatic Ductal/drug therapyCarcinoma, Pancreatic Ductal/metabolismCyclooxygenase 2 Inhibitors/administration & dosageDrug Delivery Systems/methodsHumansInflammation/complicationsInflammation/drug therapyInflammation/metabolismNF-kappa B/antagonists & inhibitorsNF-kappa B/metabolismPPAR gamma/antagonists & inhibitorsPPAR gamma/metabolismPancreatic Neoplasms/complicationsPancreatic Neoplasms/drug therapyPancreatic Neoplasms/metabolismPancreatitis/complicationsPancreatitis/drug therapyPancreatitis/metabolismReactive Oxygen Species/antagonists & inhibitorsReactive Oxygen Species/metabolism
Substances： See more » Antineoplastic AgentsCyclooxygenase 2 InhibitorsNF-kappa BPPAR gammaReactive Oxygen Species
Year: 2010 PMID： 20601821
Source DB: PubMed Journal: JOP ISSN： 1590-8577